Unknown

Dataset Information

0

Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.


ABSTRACT: Electrocardiographic (ECG) left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular (CV) morbidity and mortality. However, the predictive value of ECG LVH in treated hypertensive patients remains unclear.A total of 33,357 patients (aged ? 55 years) with hypertension and at least 1 other coronary heart disease (CHD) risk factor were randomized to chlorthalidone, amlodipine, or lisinopril. The outcome of the present study was all-cause mortality; and secondary endpoints were CHD, nonfatal myocardial infarction (MI), stroke, angina, heart failure (HF), and peripheral arterial disease. Cornell voltage criteria (S in V3 + R in aVL > 28 [men] or >22 mm [women]) defined ECG LVH.ECGs were available at baseline in 26,384 patients. Baseline Cornell voltage LVH was present in 1,741 (7%) patients, who were older (67.4 vs. 66.6 years, P < 0.001), more likely to be female (74 vs. 44%, P < 0001) with a higher systolic blood pressure (151 vs. 146 mm Hg, P < 0.001) than patients without ECG LVH. During 5.0 ± 1.4 years mean follow-up, baseline and in-study ECG LVH was significantly associated with 29 to 98% increased risks of all-cause mortality, MI, CHD, stroke, and HF in multivariable Cox analyses.Baseline Cornell voltage LVH is associated with increased CV morbidity and all-cause mortality in treated hypertensive patients independent of treatment modality and other CV risk factors.Trial Number NCT00000542.

SUBMITTER: Bang CN 

PROVIDER: S-EPMC5861536 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.

Bang Casper N CN   Soliman Elsayed Z EZ   Simpson Lara M LM   Davis Barry R BR   Devereux Richard B RB   Okin Peter M PM  

American journal of hypertension 20170901 9


<h4>Background</h4>Electrocardiographic (ECG) left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular (CV) morbidity and mortality. However, the predictive value of ECG LVH in treated hypertensive patients remains unclear.<h4>Methods</h4>A total of 33,357 patients (aged ≥ 55 years) with hypertension and at least 1 other coronary heart disease (CHD) risk factor were randomized to chlorthalidone, amlodipine, or lisinopril. The outcome of the present study was all-cause mortality  ...[more]

Similar Datasets

| S-EPMC9924839 | biostudies-literature
| S-EPMC8803820 | biostudies-literature
| S-EPMC2525851 | biostudies-other
| S-EPMC4568146 | biostudies-literature
| S-EPMC6490114 | biostudies-literature
| S-EPMC4750022 | biostudies-other
| S-EPMC5291170 | biostudies-literature
| S-EPMC4661370 | biostudies-literature
| S-EPMC3202073 | biostudies-literature
| S-EPMC5549337 | biostudies-literature